ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,454Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1749

$2.43M Total Retail Price of All Prescriptions

Rank: 4 out of 1749

324 Patients Receiving at Least One Drug in Part D
9%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

10% of this provider’s 722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$181 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
TRAZODONE HCL 942 58 1 2
TRIHEXYPHENIDYL HCL 730 52 R 10 2 33
BENZTROPINE MESYLATE 639 21 R 3 3
ABILIFY 637 73 4 5
INVEGA SUSTENNA 607 18 10 5 32
OLANZAPINE 538 31 6 6
HALOPERIDOL 533 55 7 21
METOPROLOL SUCCINATE 496 19 8 94
CLOZAPINE 492 0 9 11
DIVALPROEX SODIUM ER 471 0 10 13
HALOPERIDOL DECANOATE 373 27 11 50
FLUPHENAZINE HCL 348 12 10 12 36
ZOLPIDEM TARTRATE 319 12 13 9
AMANTADINE 276 20 14 92
FLUOXETINE HCL 265 22 15 8
INVEGA 236 0 16 45
LAMOTRIGINE 217 0 17 14
BUPROPION XL 205 0 18 18
FAZACLO 200 0 19 34
RISPERIDONE 195 14 20 1
QUETIAPINE FUMARATE 186 0 21 4
OMEPRAZOLE 176 0 22 60
GABAPENTIN 166 14 23 27
HYDROCHLOROTHIAZIDE 157 0 24 88
METOPROLOL TARTRATE 145 0 25 99
DIVALPROEX SODIUM 140 16 26 15
LISINOPRIL 132 0 27 70
CLOMIPRAMINE HCL 129 0 R 28 104
LITHIUM CARBONATE 129 0 28 20
METFORMIN HCL 123 11 30 63
CARBAMAZEPINE 116 0 31 46
LEVOTHYROXINE SODIUM 112 0 32 37
NIASPAN 111 0 33 124
PERPHENAZINE 103 0 34 44
TOPIRAMATE 100 13 35 29
CLONIDINE HCL 95 0 36 75
SIMVASTATIN 94 26 37 52
ACETAZOLAMIDE 90 0 38 161
DIPHENHYDRAMINE HCL 88 0 R 39 85
PRAZOSIN HCL 87 0 40 76
DONEPEZIL HCL 83 33 41 30
FLUPHENAZINE DECANOATE 83 0 41 79
ESCITALOPRAM OXALATE 77 0 43 23
HYDROXYZINE PAMOATE 76 0 R 44 43
SEROQUEL XR 75 0 45 25
CITALOPRAM HBR 66 0 46 10
IBUPROFEN 59 0 47 114
SEROQUEL 59 0 47 24
SERTRALINE HCL 58 0 49 7
ATORVASTATIN CALCIUM 58 0 49 122
BUSPIRONE HCL 57 0 51 26
PHENYTOIN SODIUM EXTENDED 53 0 52 197
THIORIDAZINE HCL 53 0 R 52 78
LATUDA 50 12 54 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.